Druvith/transformed_medDataset huggingface dataset:
What is (are) Thymoma and Thymic Carcinoma ? 
 Key Points
                    - Thymoma and thymic carcinoma are diseases in which malignant (cancer) cells form on the outside surface of the thymus.    -  Thymoma is linked with myasthenia gravis and other autoimmune diseases.    - Signs and symptoms of thymoma and thymic carcinoma include a cough and chest pain.     - Tests that examine the thymus are used to detect (find) thymoma or thymic carcinoma.    - Thymoma and thymic carcinoma are usually diagnosed, staged, and treated during surgery.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Thymoma and thymic carcinoma are diseases in which malignant (cancer) cells form on the outside surface of the thymus.
                    The thymus, a small organ that lies in the upper chest under the breastbone, is part of the lymph system. It makes white blood cells, called lymphocytes, that protect the body against infections.     There are different types of tumors of the thymus. Thymomas and thymic carcinomas are rare tumors of the cells that are on the outside surface of the thymus. The tumor cells in a thymoma look similar to the normal cells of the thymus, grow slowly, and rarely spread beyond the thymus. On the other hand, the tumor cells in a thymic carcinoma look very different from the normal cells of the thymus, grow more quickly, and have usually spread to other parts of the body when the cancer is found. Thymic carcinoma is more difficult to treat than thymoma.   For information on thymoma and thymic carcinoma in children, see the PDQ summary on Unusual Cancers of Childhood Treatment.
                
                
                    Thymoma is linked with myasthenia gravis and other autoimmune diseases.
                    People with thymoma often have autoimmune diseases as well. These diseases cause the immune system to attack healthy tissue and organs. They include:         -  Myasthenia gravis.    -  Acquired pure red cell aplasia.    -  Hypogammaglobulinemia.    -  Polymyositis.    -  Lupus erythematosus.    -  Rheumatoid arthritis.    -  Thyroiditis.    -  Sjgren syndrome.
What are the symptoms of Thymoma and Thymic Carcinoma ? 
 Signs and symptoms of thymoma and thymic carcinoma include a cough and chest pain. Thymoma and thymic carcinoma may not cause early signs or symptoms. The cancer may be found during a routine chest x-ray. Signs and symptoms may be caused by thymoma, thymic carcinoma, or other conditions. Check with your doctor if you have any of the following:         - A cough that doesn't go away.    - Chest pain.    - Trouble breathing.
How to diagnose Thymoma and Thymic Carcinoma ? 
 Tests that examine the thymus are used to detect (find) thymoma or thymic carcinoma. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -  Chest x-ray: An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, such as the chest, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.    -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body, such as the chest. This procedure is also called nuclear magnetic resonance imaging (NMRI).    -   PET scan (positron emission tomography scan): A procedure to find malignant tumor cells in the body. A small amount of radioactive glucose (sugar) is injected into a vein. The PET scanner rotates around the body and makes a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.
                    Thymoma and thymic carcinoma are usually diagnosed, staged, and treated during surgery. A biopsy of the tumor is done to diagnose the disease. The biopsy may be done before or during surgery (a mediastinoscopy or mediastinotomy), using a thin needle to remove a sample of cells. This is called a fine-needle aspiration (FNA) biopsy. Sometimes a wide needle is used to remove a sample of cells and this is called a core biopsy. A pathologist will view the sample under a microscope to check for cancer. If thymoma or thymic carcinoma is diagnosed, the pathologist will determine the type of cancer cell in the tumor. There may be more than one type of cancer cell in a thymoma. The surgeon will decide if all or part of the tumor can be removed by surgery. In some cases, lymph nodes and other tissues may be removed as well.
What is the outlook for Thymoma and Thymic Carcinoma ? 
 Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:          - The stage of the cancer.    - The type of cancer cell.    - Whether the tumor can be removed completely by surgery.     - The patient's general health.    - Whether the cancer has just been diagnosed or has recurred (come back).
what research (or clinical trials) is being done for Thymoma and Thymic Carcinoma ? 
 New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
What is (are) Small Intestine Cancer ? 
 Key Points
                    - Small intestine cancer is a rare disease in which malignant (cancer) cells form in the tissues of the small intestine.    - There are five types of small intestine cancer.    - Diet and health history can affect the risk of developing small intestine cancer.    - Signs and symptoms of small intestine cancer include unexplained weight loss and abdominal pain.    - Tests that examine the small intestine are used to detect (find), diagnose, and stage small intestine cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Small intestine cancer is a rare disease in which malignant (cancer) cells form in the tissues of the small intestine.
                    The small intestine is part of the bodys digestive system, which also includes the esophagus, stomach, and large intestine. The digestive system removes and processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from foods and helps pass waste material out of the body. The small intestine is a long tube that connects the stomach to the large intestine. It folds many times to fit inside the abdomen.
                
                
                    There are five types of small intestine cancer.
                    The types of cancer found in the small intestine are adenocarcinoma, sarcoma, carcinoid tumors, gastrointestinal stromal tumor, and lymphoma. This summary discusses adenocarcinoma and leiomyosarcoma (a type of sarcoma).    Adenocarcinoma starts in glandular cells in the lining of the small intestine and is the most common type of small intestine cancer. Most of these tumors occur in the part of the small intestine near the stomach. They may grow and block the intestine.   Leiomyosarcoma starts in the smooth muscle cells of the small intestine. Most of these tumors occur in the part of the small intestine near the large intestine.    See the following PDQ summaries for more information on small intestine cancer:          -  Adult Soft Tissue Sarcoma Treatment     -  Childhood Soft Tissue Sarcoma Treatment     -  Adult Non-Hodgkin Lymphoma Treatment     -  Childhood Non-Hodgkin Lymphoma Treatment     -  Gastrointestinal Carcinoid Tumors Treatment     -  Gastrointestinal Stromal Tumors Treatment
Who is at risk for Small Intestine Cancer? ? 
 Diet and health history can affect the risk of developing small intestine cancer. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for small intestine cancer include the following:         - Eating a high-fat diet.    - Having Crohn disease.     - Having celiac disease.    -  Having familial adenomatous polyposis (FAP).
What are the symptoms of Small Intestine Cancer ? 
 Signs and symptoms of small intestine cancer include unexplained weight loss and abdominal pain. These and other signs and symptoms may be caused by small intestine cancer or by other conditions. Check with your doctor if you have any of the following:          - Pain or cramps in the middle of the abdomen.    - Weight loss with no known reason.     - A lump in the abdomen.     -  Blood in the stool.
What is the outlook for Small Intestine Cancer ? 
 Certain factors affect prognosis (chance of recovery) and treatment options.The prognosis (chance of recovery) and treatment options depend on the following:          - The type of small intestine cancer.     - Whether the cancer is in the inner lining of the small intestine only or has spread into or beyond the wall of the small intestine.    - Whether the cancer has spread to other places in the body, such as the lymph nodes, liver, or peritoneum (tissue that lines the wall of the abdomen and covers most of the organs in the abdomen).    -  Whether the cancer can be completely removed by surgery.    - Whether the cancer is newly diagnosed or has recurred.
What are the stages of Small Intestine Cancer ? 
 Key Points
                    - Tests and procedures to stage small intestine cancer are usually done at the same time as diagnosis.     - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    - Small intestine cancer is grouped according to whether or not the tumor can be completely removed by surgery.
                
                
                    Tests and procedures to stage small intestine cancer are usually done at the same time as diagnosis.
                    Staging is used to find out how far the cancer has spread, but treatment decisions are not based on stage. See the General Information section for a description of tests and procedures used to detect, diagnose, and stage small intestine cancer.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
                
                
                    Cancer may spread from where it began to other parts of the body.
                    When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began (the primary tumor) and travel through the lymph system or blood.         - Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor (metastatic tumor) in another part of the body.    - Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if small intestine cancer spreads to the liver, the cancer cells in the liver are actually small intestine cancer cells. The disease is metastatic small intestine cancer, not liver cancer.
                
                
                    Small intestine cancer is grouped according to whether or not the tumor can be completely removed by surgery.
                    Treatment depends on whether the tumor can be removed by surgery and if the cancer is being treated as a primary tumor or is metastatic cancer.
What is (are) Testicular Cancer ? 
 Key Points
                    - Testicular cancer is a disease in which malignant (cancer) cells form in the tissues of one or both testicles.    - Testicular cancer is the most common cancer in men aged 15 to 34 years.    - Testicular cancer can usually be cured.    - A condition called cryptorchidism (an undescended testicle) is a risk factor for testicular cancer.
                
                
                    Testicular cancer is a disease in which malignant (cancer) cells form in the tissues of one or both testicles.
                    The testicles are 2 egg-shaped glands inside the scrotum (a sac of loose skin that lies directly below the penis). The testicles are held within the scrotum by the spermatic cord. The spermatic cord also contains the vas deferens and vessels and nerves of the testicles.     The testicles are the male sex glands and make testosterone and sperm. Germ cells in the testicles make immature sperm. These sperm travel through a network of tubules (tiny tubes) and larger tubes into the epididymis (a long coiled tube next to the testicles). This is where the sperm mature and are stored.   Almost all testicular cancers start in the germ cells. The two main types of testicular germ cell tumors are seminomas and nonseminomas.    See the PDQ summary on Testicular Cancer Treatment for more information about testicular cancer.
Who is at risk for Testicular Cancer? ? 
 Testicular cancer is the most common cancer in men aged 15 to 34 years. Testicular cancer is very rare, but it is the most common cancer found in men between the ages of 15 and 34. White men are four times more likely than black men to have testicular cancer
What is the outlook for Testicular Cancer ? 
 Testicular cancer can usually be cured. Although the number of new cases of testicular cancer has doubled in the last 40 years, the number of deaths caused by testicular cancer has decreased greatly because of better treatments. Testicular cancer can usually be cured, even in late stages of the disease. (See the PDQ summary on Testicular Cancer Treatment for more information.)
Who is at risk for Testicular Cancer? ? 
 A condition called cryptorchidism (an undescended testicle) is a risk factor for testicular cancer. Anything that increases the chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk to your doctor if you think you may be at risk. Risk factors for testicular cancer include the following:          - Having cryptorchidism (an undescended testicle).    - Having a testicle that is not normal, such as a small testicle that does not work the way it should.    - Having testicular carcinoma in situ.    - Being white.    - Having a personal or family history of testicular cancer.    - Having Klinefelter syndrome.        Men who have cryptorchidism, a testicle that is not normal, or testicular carcinoma in situ have an increased risk of testicular cancer in one or both testicles, and need to be followed closely.
Who is at risk for Testicular Cancer? ? 
 Health history can affect the risk of testicular cancer.
	                    Anything that increases the chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for testicular cancer include:          - Having had an undescended testicle.    - Having had abnormal development of the testicles.    - Having a personal history of testicular cancer.    - Having a family history of testicular cancer (especially in a father or brother).    - Being white.
	                
	                
	                    Treatment for testicular cancer can cause infertility.
	                    Certain treatments for testicular cancer can cause infertility that may be permanent. Patients who may wish to have children should consider sperm banking before having treatment. Sperm banking is the process of freezing sperm and storing it for later use.
what research (or clinical trials) is being done for Testicular Cancer ? 
 New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
What is (are) Hairy Cell Leukemia ? 
 Key Points
                    - Hairy cell leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).    - Leukemia may affect red blood cells, white blood cells, and platelets.    - Gender and age may affect the risk of hairy cell leukemia.     - Signs and symptoms of hairy cell leukemia include infections, tiredness, and pain below the ribs.     - Tests that examine the blood and bone marrow are used to detect (find) and diagnose hairy cell leukemia.    - Certain factors affect treatment options and prognosis (chance of recovery).
                
                
                    Hairy cell leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).
                    Hairy cell leukemia is a cancer of the blood and bone marrow. This rare type of leukemia gets worse slowly or does not get worse at all. The disease is called hairy cell leukemia because the leukemia cells look "hairy" when viewed under a microscope.
                
                
                    Leukemia may affect red blood cells, white blood cells, and platelets.
                    Normally, the bone marrow makes blood stem cells (immature cells) that become mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell.    A myeloid stem cell becomes one of three types of mature blood cells:         -  Red blood cells that carry oxygen and other substances to all tissues of the body.    -  White blood cells that fight infection and disease.    -  Platelets that form blood clots to stop bleeding.        A lymphoid stem cell becomes a lymphoblast cell and then into one of three types of lymphocytes (white blood cells):          -  B lymphocytes that make antibodies to help fight infection.    -  T lymphocytes that help B lymphocytes make antibodies to help fight infection.    -  Natural killer cells that attack cancer cells and viruses.         In hairy cell leukemia, too many blood stem cells become lymphocytes. These lymphocytes are abnormal and do not become healthy white blood cells. They are also called leukemia cells. The leukemia cells can build up in the blood and bone marrow so there is less room for healthy white blood cells, red blood cells, and platelets. This may cause infection, anemia, and easy bleeding. Some of the leukemia cells may collect in the spleen and cause it to swell.   This summary is about hairy cell leukemia. See the following PDQ summaries for information about other types of leukemia:         -  Adult Acute Lymphoblastic Leukemia Treatment.    -  Childhood Acute Lymphoblastic Leukemia Treatment.    -  Chronic Lymphocytic Leukemia Treatment.    -  Adult Acute Myeloid Leukemia Treatment.    -  Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment.    -  Chronic Myelogenous Leukemia Treatment.
Who is at risk for Hairy Cell Leukemia? ? 
 Gender and age may affect the risk of hairy cell leukemia. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. The cause of hairy cell leukemia is unknown. It occurs more often in older men.